Questions re generic IPE vs brand Vascepa | AMRN Message Board Posts

Amarin Corporation plc

  AMRN website

AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  7852 of 8065  at  11/25/2020 3:02:55 PM  by

ex_hacker202


 In response to msg 7845 by  cmm3rd
view thread

Re: Questions re generic IPE vs brand Vascepa

  Yes - when the details of Hikma's GV came out and initially made no sense I weighed two of my 0.5 g caps of V, they weighed 1.45g combined. Label says they contain 0.5 g of IPE, so the capsule is 33% of total weight - I was really surprised about that. For GV to meet bioequivalency they have to have at least 90% of the brand name's active ingredients - I believe I've previously posted about this, something called "The myth of the 80%-120% rule" or something similar, so I'm assuming a 1 g cap of GV also weighs ~ 1.5 g - that guy on Youtube measured V and GV, cut them open to smell them, but he didn't weigh them to compare. FDA's AB rating means it's therapeutically equivalent to brand name - docs will rightly assume that GV should work just as well for the R-IT indication - I mean how could they not? There's no logical reason to believe a generic the FDA says is equivalent to the brand should work for TGs but not for CVD - that's partly what got Teva in trouble with GSK - the promoted that generic drug for patented uses (CHF?) and docs prescribed it for that use.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
7855 Re: Questions re generic IPE vs brand Vascepa cmm3rd 0 11/25/2020 3:50:06 PM








Financial Market Data provided by
.
Loading...